0001209191-23-036350.txt : 20230612 0001209191-23-036350.hdr.sgml : 20230612 20230612164828 ACCESSION NUMBER: 0001209191-23-036350 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230612 FILED AS OF DATE: 20230612 DATE AS OF CHANGE: 20230612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klassen Preston CENTRAL INDEX KEY: 0001493056 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 231008783 MAIL ADDRESS: STREET 1: 3344 N. TORREY PINES COURT, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4224 CAMPUS POINT COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 4224 CAMPUS POINT COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-12 0 0001505512 Regulus Therapeutics Inc. RGLS 0001493056 Klassen Preston C/O REGULUS THERAPEUTICS INC. 4224 CAMPUS POINT CT., #210 SAN DIEGO CA 92121 0 1 0 0 President & Head of R & D 0 Stock Option (Right to Buy) 1.46 2023-06-12 4 A 0 350000 0.00 A 2033-06-11 Common Stock 350000 350000 D 25% of the shares vest one year following the date of grant and the remainder of the shares vest in 36 equal installments on a monthly basis thereafter, such that the option is fully vested three years following the date of grant, subject to the reporting person's continuous service. Christopher Aker, Attorney in Fact 2023-06-12